Icad Inc Stock Today

ICAD Stock  USD 1.77  0.16  9.94%   


0 of 100

Very Weak

Odds Of Distress

Less than 36

Below Average
Icad is trading at 1.77 as of the 3rd of December 2023, a 9.94 percent up since the beginning of the trading day. The stock's lowest day price was 1.62. Icad has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Icad Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of October 2023 and ending today, the 3rd of December 2023. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
3rd of December 1986
Health Care
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire. The company has 26.35 M outstanding shares of which 596.84 K shares are currently shorted by private and institutional investors with about 3.61 trading days to cover. More on Icad Inc

Moving together with Icad Stock

+0.87EWEdwards Lifesciences Corp Fiscal Quarter End 31st of December 2023 PairCorr
+0.83GHGuardant Health Fiscal Quarter End 31st of December 2023 PairCorr
+0.9OMOutset MedicalInc Fiscal Quarter End 31st of December 2023 PairCorr

Moving against Icad Stock

-0.65EKSOEkso Bionics Holdings Fiscal Quarter End 31st of December 2023 PairCorr
-0.61ENSGEnsign Group Fiscal Quarter End 31st of December 2023 PairCorr

Icad Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Icad's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Icad or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and DirectorKenneth Ferry
SEC FilingsIcad Security & Exchange Commission EDGAR Reports
Business ConcentrationHealth Care Technology, Health Care Equipment & Services, Health Care (View all Sectors)
Average Analyst Recommendation
Analysts covering Icad report their recommendations after researching Icad's financial statements, talking to executives and customers, or listening in on Icad's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Icad Inc. The Icad consensus assessment is calculated by taking the average forecast from all of the analysts covering Icad.
Strong Buy2 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Icad Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Icad Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted23.3 M25.2 M
Significantly Down
Slightly volatile
Weighted Average Shares23.3 M25.2 M
Significantly Down
Slightly volatile
Net Cash Flow from Operations(13.1 M)(12.8 M)
Fairly Down
Slightly volatile
Current Liabilities13.8 M13.5 M
Fairly Up
Pretty Stable
Total Liabilities19.1 M16.8 M
Moderately Up
Slightly volatile
Gross Margin0.780.709
Significantly Up
Slightly volatile
Total Debt689.7 K672 K
Fairly Up
Slightly volatile
Asset Turnover0.660.57
Fairly Up
Slightly volatile
Current Assets37.9 M38.2 M
Slightly Down
Slightly volatile
Total Assets49.2 M51.7 M
Notably Down
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Icad's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Icad's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Icad's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Icad's financial leverage. It provides some insight into what part of Icad's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Icad's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Icad deploys its capital and how much of that capital is borrowed.
Icad cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 3.38 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Icad Inc has a current ratio of 3.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Icad until it has trouble settling it off, either with new capital or with free cash flow. So, Icad's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Icad Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Icad to invest in growth at high rates of return. When we think about Icad's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(13.13 Million)
Icad Inc (ICAD) is traded on NASDAQ Exchange in USA. It is located in 98 Spit Brook Road, Nashua, NH, United States, 03062 and employs 108 people. Icad is listed under Health Care Technology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.64 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Icad's market, we take the total number of its shares issued and multiply it by Icad's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Icad Inc conducts business under Health Care Technology sector and is part of Health Care industry. The entity has 26.35 M outstanding shares of which 596.84 K shares are currently shorted by private and institutional investors with about 3.61 trading days to cover. Icad Inc currently holds about 27.18 M in cash with (12.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.07.
Check Icad Probability Of Bankruptcy
Icad Inc has a total of twenty-six million three hundred fifty-two thousand seven hundred outstanding shares. 30% of Icad Inc outstanding shares are owned by outside corporations. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulation than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or about to change. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Icad Ownership Details

Icad Stock Price Odds Analysis

What are Icad's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Icad jumping above the current price in 90 days from now is about 46.48%. The Icad Inc probability density function shows the probability of Icad stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.2731. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Icad will likely underperform. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Icad Inc is significantly underperforming NYSE Composite.
  Odds Below 1.77HorizonTargetOdds Above 1.77
53.42%90 days
Based on a normal probability distribution, the odds of Icad to move above the current price in 90 days from now is about 46.48 (This Icad Inc probability density function shows the probability of Icad Stock to fall within a particular range of prices over 90 days) .

Icad Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Icad that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Icad's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Icad's value.
InstituionLast TransactionTypeSharesValue
Portolan Capital Management Llc2023-09-30Common Shares1.2 M2.6 M
Vanguard Group Inc2023-09-30Common Shares1.1 M2.2 M
Granahan Investment Management Llc2023-09-30Common Shares895.2 K1.9 M
First Eagle Investment Management Llc2023-09-30Common Shares660.8 K1.4 M
Eam Investors Llc2023-09-30Common Shares420.2 K886.7 K
Blackrock Inc2023-09-30Common Shares348.7 K735.8 K
Renaissance Technologies Llc2023-09-30Common Shares339.8 K717 K
Greenwood Capital Associates Llc2023-09-30Common Shares325.3 K686.4 K
Pura Vida Investments Llc2023-03-31Common Shares383.1 K475 K
Geode Capital Management Llc2023-09-30Common Shares220.8 K466 K
General American Investors Co Inc2023-09-30Common Shares200.4 K422.9 K
View Icad Diagnostics

Icad Historical Income Statement

Icad Inc Income Statement is one of the three primary financial statements used for reporting Icad's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Icad Inc revenue and expense. Icad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Icad's Interest Expense is projected to decrease significantly based on the last few years of reporting. . The current year's Operating Expenses is expected to grow to about 36.6 M, whereas Consolidated Income is forecasted to decline to (14.7 M). View More Fundamentals

Icad Stock Against Markets

Picking the right benchmark for Icad stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Icad stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Icad is critical whether you are bullish or bearish towards Icad Inc at a given time. Please also check how Icad's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Icad without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now


Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Icad Corporate Directors

Icad corporate directors refer to members of an Icad board of directors. The board of directors generally takes responsibility for the Icad's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Icad's board members must vote for the resolution. The Icad board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Elliot SussmanIndependent DirectorProfile
Andrew SassineDirectorProfile
Somu SubramaniamIndependent DirectorProfile
Rakesh PatelDirectorProfile

How to buy Icad Stock?

Before investing in Icad, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Icad. To buy Icad stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Icad. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Icad stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Icad Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Icad Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Icad Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Icad Stock please use our How to Invest in Icad guide.

Already Invested in Icad Inc?

The danger of trading Icad Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Icad is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Icad. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Icad Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Icad Inc is a strong investment it is important to analyze Icad's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Icad's future performance. For an informed investment choice regarding Icad Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icad Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
Note that the Icad Inc information on this page should be used as a complementary analysis to other Icad's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Complementary Tools for Icad Stock analysis

When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
CEOs Directory
Screen CEOs from public companies around the world
Is Icad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icad. If investors know Icad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Icad Inc is measured differently than its book value, which is the value of Icad that is recorded on the company's balance sheet. Investors also form their own opinion of Icad's value that differs from its market value or its book value, called intrinsic value, which is Icad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icad's market value can be influenced by many factors that don't directly affect Icad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.